Rotenone and CCCP inhibit tyrosine hydroxylation in rat striatal tissue slices

Yoko Hirata1, Toshiharu Nagatsu

  • 1Department of Biomolecular Science, Faculty of Engineering, Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan. yoko@biomol.gifu-u.ac.jp

Toxicology
|August 24, 2005
PubMed

Insights

Mitochondrial toxins like rotenone and CCCP inhibit dopamine production by blocking tyrosine hydroxylation. This leads to dopamine depletion, offering insights into Parkinson

Area of Science:

  • Neuroscience
  • Biochemistry
  • Toxicology

Background:

  • Complex I inhibition is linked to neurotoxicity in Parkinson's disease models.
  • Dopaminergic neurotoxins MPTP and manganese inhibit tyrosine hydroxylation, a key step in dopamine synthesis.

Purpose of the Study:

  • To investigate the impact of mitochondrial toxins rotenone and CCCP on tyrosine hydroxylation in rat striatal slices.
  • To explore the relationship between mitochondrial dysfunction and dopamine biosynthesis.

Main Methods:

  • Incubation of rat striatal slices with rotenone and carbonyl cyanide 3-chlorophenylhydrazone (CCCP).
  • Measurement of DOPA formation, ATP levels, and lactate production.
  • Analysis of dopamine (DA), dihydroxyphenyl acetic acid (DOPAC), and homovanillic acid (HVA) levels in PC12 cells.

Main Results:

  • Rotenone and CCCP inhibited DOPA formation within 1 hour.
  • These toxins decreased ATP levels and increased lactate production, indicating mitochondrial dysfunction.
  • Rotenone exposure reduced DA, DOPAC, and HVA levels in PC12 cells after 20 hours.

Conclusions:

  • Tyrosine hydroxylation is inhibited in dopaminergic neurons upon exposure to rotenone and CCCP.
  • This inhibition leads to dopamine depletion, contributing to the neurochemical changes observed in Parkinson's disease.
  • Mitochondrial toxins disrupt dopamine biosynthesis through the inhibition of tyrosine hydroxylation.

Related Concept Videos